Neuronetics

Patient perspectives hold prominent value with venture philanthropy in action

Robert J. Beall, president of the Cystic Fibrosis Foundation, spoke to a small group of venture capitalists and biosciences entrepreneurs in San Francisco Sunday night, highlighting the importance of having patients’ voices heard when it comes to drug research. Beall, who created the model for “venture philanthropy,” said that the $3.3 billon the foundation received […]

News

Magnetic brain stimulation device for depressive disorders goes global

A magnetic brain stimulation device for depressive disorders has received CE Mark approval from European regulators, according to a statement from the company. The move paves the way for the global expansion of the device to markets in Europe, the Middle East and ultimately, Asia. Neuronetics‘ Neurostar TMS Therapy known as transcranial magnetic stimulation had […]

presented by